---

Neal Lindeman

As a current member of the College of American Pathologists’  Molecular Oncology Committee, Neal has contributed significantly to efforts to standardize molecular testing. He co-chaired the Pathology and Laboratory Quality Center expert panel that created evidence-based recommendations for lung cancer biomarkers. As an associate professor of pathology at Harvard Medical School and an associate pathologist at Brigham and Women’s Hospital, Neal studies genetic alterations in solid tumors, particularly involving growth factor signaling pathways in adenocarcinomas of the lung.

---

Part of the Power List 2015

2015

Who are the most influential laboratory medicine professionals?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015